Selezione Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.80 M
- Company Age 2 Year, 11 Months
About Selezione Diagnostics
Selezione Diagnostics Private Limited (SDPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 March 2022 (Two years and 11 months 3 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.80 M, as per Ministry of Corporate Affairs (MCA) records.
Nilesh Kulkarni, Aditya Dube, Mandar Pilgaonkar, and One other member serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U85100MH2022PTC378146
-
Company No.
378146
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Mar 2022
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Selezione Diagnostics?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nilesh Kulkarni
|
Additional Director | 01-Apr-2024 | Current |
|
Aditya Dube
|
Director | 09-Mar-2022 | Current |
|
Mandar Pilgaonkar
|
Director | 09-Mar-2022 | Current |
|
Praveen Tiwari
|
Additional Director | 15-Sep-2022 | Current |
Financial Performance of Selezione Diagnostics.
Enhance accessibility to Selezione Diagnostics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Selezione Diagnostics?
Unlock access to Selezione Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Tracus Diagnostic LlpAditya Dube is a mutual person
-
Cardioaxis Corporation Private Limited
Aditya Dube and Mandar Pilgaonkar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Selezione Diagnostics?
Selezione Diagnostics has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Selezione Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Selezione Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
